The digital health startup ecosystem has experienced a dramatic transformation from 2021 to 2024. Once buoyed by a record-breaking influx of venture capital, the landscape now appears stark and challenging for many startups. The rush of investments in 2021 brought about hopeful optimism, but the
Freya Biosciences, a transatlantic biotech company specializing in women's health, has successfully secured a substantial $10.4 million investment from the Bill & Melinda Gates Foundation, along with an additional $1.4 million in financing from the Export and Investment Fund of Denmark.
In a significant move towards revolutionizing pediatric care, Little Journey, a digital health startup, has secured £6 million in Series A funding. This development aims to enhance its personalized psychological support platform for children and families interacting with healthcare systems. As a
The Immunomodulators Market is on the cusp of exponential growth, with forecasts predicting an increase from roughly USD 217.7 billion in 2023 to an estimated USD 388.7 billion by 2032. This significant rise, characterized by an impressive compound annual growth rate (CAGR) of 6.7%, is largely
The gene therapy sector, once a beacon of hope for revolutionary treatments, has seen a significant slowdown in investment post the COVID-19 pandemic. This downturn follows a period of unprecedented financial influx during the pandemic years, raising questions about the future of this promising
South Korea's pharmaceutical and biotech industry is witnessing a fascinating shift as Contract Development and Manufacturing Organizations (CDMOs) and biosimilar developers are experiencing robust growth, while traditional pharmaceutical companies lag. At the forefront of this transition is
